XML 43 R25.htm IDEA: XBRL DOCUMENT
v3.20.4

Financial expenses, net | 12 Months Ended
--- | ---
Dec. 31, 2020
Financial expenses, net | NOTE 17—Financial expenses, net:
|  | Year ended December, 31 |
|  | 2020 |  |  | 2019 |  |  | 2018 |
|  | (U.S. $ in millions) |
Interest expenses and other bank charges |  |  | 963 |  |  |  | 881 |  |  |  | 920 |
Income from investments (1) |  |  | (104 | ) |  |  | (41 | ) |  |  | (39 | )
Foreign exchange (gains) losses, net |  |  | (26 | ) |  |  | (15 | ) |  |  | 13 |
Other, net (2) |  |  | — |  |  |  | (4 | ) |  |  | 65 |
Total finance expense, net |  | $ | 834 |  |  | $ | 822 |  |  | $ | 959 |
(1) | In 2020, Income from investments comprised mainly of revaluation gain of Teva’s investment in American Well Corporation (“American Well”). See note 20.
(2) | In 2018, Other, net comprised mainly of a make-whole payment of $46 million following early redemption of senior notes during 2018.

X
- Definition Financial Expenses Net [Text Block] + References No definition available. + Details
Name: | teva_FinancialExpensesNetTextBlock
Namespace Prefix: | teva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration